Mobile Nav


Income Statement

Aarey Drugs & Pharmaceuticals Ltd.

(₹ in Crs.) You can view the Income Statement for the last 5 years.
Market Cap. (₹) 52.03 Cr. P/BV 0.60 Book Value (₹) 37.11
52 Week High/Low (₹) 51/20 FV/ML 10/1 P/E(X) 7.95
Bookclosure 14/12/2018 EPS (₹) 2.80 Div Yield (%) 0.45
ParticularsMar 18Mar 17Mar 16Mar 15Mar 14
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
Revenue From Operations [Net]349.35395.97246.03213.44199.73
Total Operating Revenues349.35395.97246.03213.44199.73
Other Income3.183.343.142.591.58
Total Revenue352.53399.30249.17216.03201.31
Purchase Of Stock-In Trade346.93386.12239.90208.71192.15
Operating And Direct Expenses0.
Changes In Inventories Of FG,WIP And Stock-In Trade-9.56-
Employee Benefit Expenses0.380.340.260.260.41
Finance Costs1.924.331.721.490.95
Depreciation And Amortisation Expenses0.710.640.621.050.62
Other Expenses3.963.031.721.561.65
Total Expenses344.34391.33247.35214.62199.96
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax8.197.981.811.411.34
Profit/Loss Before Tax8.197.981.811.411.34
Tax Expenses-Continued Operations     
Current Tax2.252.100.520.310.30
Less: MAT Credit Entitlement0.000.000.00-0.010.01
Deferred Tax-0.240.410.000.000.00
Total Tax Expenses2.012.500.520.320.29
Profit/Loss After Tax And Before ExtraOrdinary Items6.185.471.291.091.05
Profit/Loss From Continuing Operations6.185.471.291.091.05
Profit/Loss For The Period6.185.471.291.091.05
Basic EPS (Rs.)2.643.030.770.650.63
Diluted EPS (Rs.)2.643.030.770.650.63
Attention Investors :
Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile / email at the end of the day .......... Issued in the interest of investors
Attention Investors :
Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day......................issued in the interest of investors.
Attention Investors :
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Attention Investors :
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
“Investment in securities market are subject to market risks, read all the related documents carefully before investing”.